HVA22C Antibody

What is HVA22C and what cellular functions does it regulate?

HVA22C belongs to the HVA22 gene family, which is found in diverse eukaryotic organisms including plants, animals, fungi, and protists . The HVA22 protein was originally identified as a transcript accumulating in barley (Hordeum vulgare) aleurone tissue upon treatment with abscisic acid (ABA) and is induced by environmental stresses such as dehydration, salinity, and extreme temperatures .

Functionally, HVA22 proteins regulate vesicular traffic in stressed cells, either to facilitate membrane turnover or to decrease unnecessary secretion . The region of highest homology among HVA22 family members is a short hydrophilic loop flanked by two hydrophobic stretches, while the C-terminal region shows the highest degree of variability between species . Research in yeast models demonstrates that deletion of YOP1 (the yeast HVA22 homolog) combined with mutations in interacting proteins leads to defects in vesicular traffic, evidenced by the accumulation of transport vesicles and decreased invertase secretion .

What are the recommended applications and dilutions for HVA22C antibody use in common experimental techniques?

While the search results don't specifically detail HVA22C antibody, we can extrapolate from REEP5 antibody data (a related protein) for common applications. For optimal results in different experimental techniques, researchers should consider the following recommended dilutions:

It is recommended that researchers titrate the antibody in each testing system to obtain optimal results, as performance may be sample-dependent . For immunohistochemistry applications, antigen retrieval with TE buffer pH 9.0 is suggested, with citrate buffer pH 6.0 as an alternative .

What tissues and cell lines have been validated for HVA22C antibody reactivity?

Based on related antibody data, researchers should expect reactivity across multiple human, mouse, and rat samples. Validated samples for detection include:

When designing experiments, researchers should select appropriate positive controls from these validated samples to ensure experimental validity .

How should researchers design experiments to study HVA22C expression changes under various stress conditions?

When investigating HVA22C expression changes under stress conditions, researchers should implement a comprehensive experimental design that accounts for temporal dynamics and multiple stressors. Based on existing protocols for HVA22 family genes, the following approach is recommended:

• Plant/Cell Selection: Use 4-week-old plant specimens or appropriate cell cultures maintained under controlled conditions .

• Stress Treatments Setup:

  • Salt stress: Apply NaCl solution (250 mM) until soil saturation

  • Drought stress: Saturate soil with PEG6000 (10%) solution

  • Hormonal stress: Spray leaves with 500 μM ABA solution

  • Control: Water with regular water until soil saturation

• Sample Collection Timeline: Collect samples at multiple time points (0, 3, 6, 12, and 24 hours after treatment) to capture the temporal dynamics of expression changes .

• Tissue Sampling: Collect multiple tissue types (roots, stems, and leaves) separately to assess tissue-specific responses .

• RNA Extraction and qPCR Analysis:

  • Extract total RNA using a reliable RNA isolation kit

  • Perform reverse transcription to generate cDNA

  • Design specific primers using NCBI primer design tools

  • Use housekeeping genes (such as UBQ14) as internal controls

  • Calculate relative expression using the 2^-ΔΔCt method

This experimental design allows for comprehensive analysis of HVA22C expression dynamics across different tissues, stressors, and time points, providing insights into its role in stress response pathways.

What are the challenges in distinguishing between HVA22C and other family members in experimental settings?

Distinguishing between HVA22C and other family members presents significant challenges due to their structural similarities and potential functional redundancy. Several methodological approaches can address these challenges:

• Antibody Specificity Validation: Before conducting experiments, researchers must rigorously validate antibody specificity through:

  • Western blot analysis with recombinant proteins of each family member

  • Testing antibody reactivity in knockout/knockdown models of specific HVA22 family members

  • Peptide competition assays to confirm epitope specificity

• Sequence Homology Challenges: HVA22 family members share regions of high sequence homology, particularly in the short hydrophilic loop flanked by two hydrophobic stretches . When designing detection methods, researchers should:

  • Target the C-terminal region which shows the highest degree of variability between species for specific detection

  • Perform multiple sequence alignments to identify unique epitopes for each family member

  • Design primers or probes that span variable regions for specific nucleic acid detection

• Expression Pattern Analysis: Different HVA22 family members show differential expression patterns in response to hormonal and developmental signals . Researchers should:

  • Compare expression profiles across multiple conditions

  • Use appropriate housekeeping genes for normalization

  • Employ multi-parameter analysis to differentiate expression dynamics

• Functional Redundancy Testing: Design experiments that can distinguish functional redundancy through:

  • Systematic knockdown/knockout of individual and multiple family members

  • Rescue experiments with specific family members

  • Domain-swapping experiments to identify functional specificity determinants

What methodological approaches are most effective for studying HVA22C protein interactions and their functional significance?

To effectively study HVA22C protein interactions and their functional significance, researchers should employ multiple complementary methodological approaches:

• Yeast Two-Hybrid (Y2H) Screening: Based on previous successful application with HVA22 homologs, Y2H can identify potential protein interactors. The yeast HVA22 homolog (Yop1p) has been shown to interact with GTPase-interacting protein Yip1p, which provides a foundation for studying similar interactions of HVA22C .

• Co-Immunoprecipitation (Co-IP): Using validated antibodies, researchers can:

  • Perform Co-IP using the recommended dilution of 0.5-4.0 μg antibody for 1.0-3.0 mg of total protein lysate

  • Validate interactions in both native conditions and with tagged overexpression systems

  • Perform reverse Co-IP to confirm specificity of interactions

• Proximity Labeling Techniques:

  • BioID or TurboID fusion proteins can identify proximal interacting partners in living cells

  • APEX2-based proximity labeling can capture transient interactions

  • Analyze labeled proteins using mass spectrometry for comprehensive interaction mapping

• Functional Validation Through Genetic Approaches:

  • Generate synthetic enhancement mutants as demonstrated with yeast YOP1 and SEY1

  • The double mutant of yop1 and sey1 showed defects in vesicular traffic, evidenced by accumulation of transport vesicles and decreased invertase secretion

  • Apply similar approaches in other model systems to identify genes that genetically interact with HVA22C

• Subcellular Localization Studies:

  • Perform immunofluorescence analysis using antibody dilutions of 1:50-1:500

  • Combine with markers for different subcellular compartments to determine precise localization

  • Use live-cell imaging with fluorescently tagged proteins to track dynamic interactions

• Biochemical Assays for Functional Assessment:

  • Measure vesicular trafficking rates in the presence and absence of HVA22C

  • Assess membrane morphology and dynamics using electron microscopy

  • Quantify secretion rates of reporter proteins to assess functional impacts on secretory pathways

What strategies can address non-specific binding when using HVA22C antibodies in Western blot applications?

Non-specific binding in Western blot applications can significantly compromise experimental results. To address this issue with HVA22C antibodies, researchers should consider the following methodological strategies:

• Optimize Antibody Dilution: Titrate the antibody concentration across a wide range (1:2000-1:10000 for polyclonal or up to 1:100000 for monoclonal antibodies) to identify the optimal signal-to-noise ratio . The recommended starting dilution should be adjusted based on your specific experimental conditions and protein abundance.

• Blocking Optimization:

  • Test different blocking agents (BSA, non-fat dry milk, commercial blocking solutions)

  • Increase blocking time from 1 hour to overnight at 4°C

  • Add 0.1-0.3% Tween-20 to blocking and washing buffers to reduce hydrophobic interactions

• Stringent Washing Protocol:

  • Increase the number of washes (5-6 times for 10 minutes each)

  • Use higher concentration of detergent (0.1% to 0.3% Tween-20) in wash buffers

  • Perform one high-salt wash (500 mM NaCl) to disrupt low-affinity interactions

• Sample Preparation Modifications:

  • Ensure complete denaturation of protein samples (heat at 95°C for 5-10 minutes in Laemmli buffer)

  • Add reducing agents (β-mercaptoethanol or DTT) to disrupt disulfide bonds

  • Pre-clear lysates by centrifugation at high speed (14,000 × g for 15 minutes)

• Validation Controls:

  • Include knockout/knockdown samples as negative controls

  • Pre-absorb antibody with recombinant target protein

  • Use secondary antibody-only controls to identify non-specific binding from secondary antibodies

• Consider the Observed Molecular Weight:

  • The expected molecular weight of HVA22 family proteins is 18-21 kDa (based on REEP5 data)

  • Confirm bands at this molecular weight and investigate any unexpected bands

How can researchers optimize immunohistochemistry protocols for detecting low-abundance HVA22C expression in tissue samples?

Detecting low-abundance HVA22C expression in tissue samples requires careful optimization of immunohistochemistry protocols. Based on experimental data with related proteins, the following methodological approaches are recommended:

• Tissue Preparation and Fixation:

  • Optimize fixation time (4-24 hours) with 10% neutral buffered formalin

  • Use freshly prepared samples when possible

  • Perform antigen retrieval with TE buffer pH 9.0 as a primary option or citrate buffer pH 6.0 as an alternative

  • Extend antigen retrieval time to 20-30 minutes for difficult samples

• Signal Amplification Methods:

  • Implement tyramide signal amplification (TSA) systems to enhance detection sensitivity

  • Use polymer-based detection systems rather than traditional ABC methods

  • Consider sequential antibody application with multiple rounds of signal development

  • Apply avidin-biotin blocking for tissues with high endogenous biotin

• Antibody Concentration and Incubation:

  • Start with a higher antibody concentration (1:300) for low-abundance targets

  • Extend primary antibody incubation to overnight at 4°C

  • Use humidity chambers to prevent evaporation during long incubations

  • Add protein carriers (0.1-1% BSA) to antibody diluents

• Background Reduction Techniques:

  • Block endogenous peroxidase with 3% H₂O₂ for 10-15 minutes

  • Apply additional blocking with 5-10% normal serum from the same species as the secondary antibody

  • Include 0.1-0.3% Triton X-100 for improved antibody penetration

  • Use specialized background reducers for problematic tissues

• Optimized Detection Systems:

  • Select highly sensitive chromogens (e.g., DAB with nickel enhancement)

  • For fluorescence detection, use directly conjugated antibodies or bright fluorophores

  • Employ spectral imaging to separate signal from autofluorescence

  • Consider sequential scanning in confocal microscopy

• Technical Controls and Validation:

  • Include positive control tissues with known expression

  • Prepare absorption controls by pre-incubating antibody with recombinant protein

  • Use isotype controls to assess non-specific binding

  • Perform parallel detection with multiple antibodies targeting different epitopes

How can HVA22C antibodies be effectively incorporated into multi-omics research approaches?

Integrating HVA22C antibodies into multi-omics research requires strategic planning to maximize data integration across different analytical platforms. The following approach enables comprehensive characterization of HVA22C biology:

• Proteomics Integration:

  • Use HVA22C antibodies for immunoprecipitation followed by mass spectrometry to identify protein complexes

  • Apply the recommended antibody concentration (0.5-4.0 μg for 1.0-3.0 mg of total protein lysate)

  • Compare immunoprecipitation results with predicted interaction networks from computational analyses

  • Validate key interactions using reciprocal co-immunoprecipitation

• Transcriptomics Correlation:

  • Correlate HVA22C protein levels (detected by Western blot) with mRNA expression data

  • Design experiments that parallel RNA-seq time points with protein analysis time points

  • Apply gene expression analysis techniques similar to those used for HVA22 family members in cotton

  • Analyze promoter regions for cis-acting elements that might explain expression patterns

• Functional Genomics Approaches:

  • Combine CRISPR-Cas9 gene editing with antibody-based protein detection

  • Implement synthetic genetic interaction screens similar to those used with YOP1 in yeast

  • Generate expression constructs for overexpression studies as demonstrated with GhHVA22E1D

  • Develop virus-induced gene silencing (VIGS) systems for functional analysis

• Spatial Omics Analysis:

  • Apply immunofluorescence techniques (1:50-1:500 dilution) for spatial protein distribution

  • Combine with in situ hybridization to correlate protein and mRNA localization

  • Integrate with tissue-specific transcriptomics data

  • Use multiplexed imaging with other markers to define cellular contexts

• Stress Response Network Mapping:

  • Design experimental time courses similar to those used for HVA22 genes in cotton (0, 3, 6, 12, and 24 hours)

  • Apply multiple stressors (salt, drought, ABA) to build comprehensive response networks

  • Correlate changes in HVA22C protein levels with global proteomic and phosphoproteomic changes

  • Map HVA22C to specific cellular pathways activated during stress responses

What are the best practices for determining HVA22C post-translational modifications and their functional significance?

Investigating post-translational modifications (PTMs) of HVA22C requires specialized techniques that go beyond standard antibody applications. Researchers should implement the following methodological approaches:

• PTM-Specific Antibody Validation:

  • Validate antibody specificity using synthetic peptides with and without specific modifications

  • Compare reactivity in wild-type versus mutagenized samples (where potential modification sites are altered)

  • Perform antibody specificity tests with enzymatic removal of specific modifications

  • Establish detection limits and linear response ranges for quantitative applications

• Mass Spectrometry-Based PTM Mapping:

  • Use immunoprecipitation with HVA22C antibodies followed by MS/MS analysis

  • Apply enrichment strategies for specific modifications (phosphopeptide enrichment, ubiquitin remnant motif antibodies)

  • Implement both bottom-up (peptide-level) and top-down (intact protein) proteomics approaches

  • Compare PTM profiles under normal and stress conditions to identify regulated modifications

• Site-Directed Mutagenesis for Functional Validation:

  • Generate point mutations at predicted modification sites

  • Create phosphomimetic (S/T to D/E) and phospho-null (S/T to A) mutations

  • Perform complementation experiments in knockout backgrounds

  • Assess protein-protein interactions with wild-type versus mutant forms

• Signaling Pathway Analysis:

  • Identify kinases, phosphatases, or other modifying enzymes that target HVA22C

  • Use pharmacological inhibitors or genetic manipulation of candidate modifying enzymes

  • Monitor dynamic changes in modifications during stress responses

  • Map modification sites to functional domains within the protein structure

• Structural Biology Approaches:

  • Generate structural models that incorporate PTMs

  • Assess how modifications affect protein conformation using circular dichroism or structural proteomics

  • Analyze the impact of modifications on hydrophobic domains and membrane interactions

  • Consider the highly conserved hydrophilic loop flanked by two hydrophobic stretches as potential modification targets

How do HVA22C antibodies perform across different model organisms, and what controls should be implemented?

HVA22 proteins are highly conserved across diverse eukaryotic organisms, requiring careful consideration when using antibodies across different species. The following methodological approach ensures rigorous cross-species analysis:

• Epitope Conservation Analysis:

  • Perform sequence alignment of target epitopes across species of interest

  • Assess percent identity and similarity in epitope regions

  • Predict cross-reactivity based on conservation of critical amino acid residues

  • Consider that the region of highest homology is a short hydrophilic loop flanked by two hydrophobic stretches

• Validated Species Reactivity:

  • Based on related antibody data, expect reactivity with human, mouse, rat, and possibly pig samples

  • For studies in other organisms, preliminary validation is essential

  • The cited reactivity of similar antibodies includes human, mouse, monkey, and xenopus

• Control Selection Strategy:

  • Include tissue from knockout/knockdown models as negative controls

  • Use recombinant proteins from the species being studied as positive controls

  • When testing new species, run parallel samples from validated species

  • Consider species-specific differences in molecular weight (18-21 kDa range observed)

• Optimization for Novel Species:

  • Test multiple antibody dilutions across a broader range than recommended

  • Modify extraction buffers to account for species-specific differences in sample preparation

  • Adjust blocking conditions to control for species-specific background

  • Optimize secondary antibody selection for the host species

• Functional Conservation Validation:

  • Correlate antibody detection with functional assays across species

  • Consider functional differences between homologs (e.g., yeast vs. plant HVA22 proteins)

  • Validate subcellular localization patterns across different species

  • Compare stress response patterns in diverse organisms

What are the key considerations when comparing HVA22C expression and function between plant and animal systems?

Comparing HVA22C expression and function between plant and animal systems presents unique challenges due to evolutionary divergence while maintaining conserved core functions. Researchers should consider the following methodological approaches:

• Evolutionary Context Analysis:

  • Understand that HVA22 homologs exist in diverse eukaryotic organisms including plants, animals, fungi, and protists

  • Consider that plant systems may have multiple HVA22 homologs (e.g., Arabidopsis has at least five)

  • Account for structural differences: animal and fungal homologs contain a 40-48 amino acid N-terminal region absent in plant homologs

  • Analyze C-terminal regions which show the highest variability between species while remaining hydrophilic in all cases

• Expression Regulation Differences:

  • In plants, HVA22 expression is induced by environmental stresses (dehydration, salinity, extreme temperatures) and ABA

  • Plant HVA22 genes contain specific cis-acting elements associated with stress response and hormonal regulation

  • Expression analysis should account for tissue-specific differences between plant and animal systems

  • Design parallel stress experiments appropriate for each system (e.g., osmotic stress for both)

• Functional Comparison Strategies:

  • Focus on vesicular trafficking as a conserved function across kingdoms

  • Develop comparable assays for membrane turnover and secretion in both systems

  • Leverage yeast models as an intermediate system for functional studies

  • Consider that the synthetic enhancement of yeast YOP1 with SEY1 provides a framework for identifying functional partners in other systems

• Subcellular Localization Comparisons:

  • Use immunofluorescence techniques with appropriate dilutions (1:50-1:500)

  • Compare localization patterns relative to conserved organelle markers

  • Account for differences in cell architecture between plant and animal cells

  • Analyze protein-protein interactions in the context of subcellular compartmentalization

• Methodological Adaptations:

  • Modify extraction protocols to account for differences in cell wall (plants) versus cell membrane (animals)

  • Adapt fixation and permeabilization protocols for immunohistochemistry and immunofluorescence

  • Consider differences in genetic manipulation techniques between systems

  • Develop parallel experimental timelines that account for different growth and development rates

By implementing these methodological approaches, researchers can effectively compare HVA22C biology across divergent eukaryotic systems while accounting for both conserved functions and evolutionary adaptations.